Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs SkinnyRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and SkinnyRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 356 · Grade C

SkinnyRx

Visit SkinnyRx Full brief →

FDA warning letter, February 2026 — issued to Lean Rx, Inc. dba SkinnyRx. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 58 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make SkinnyRx a bad call — it's best for readers who will not inject and want a tablet at no premium over the injection, and who will check which term a "$199" is attached to before treating it as a monthly bill. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
54
Supply Reliability
95
58
Transparency
90
62
Access Breadth
93
74
Clinical Oversight
92
55
Track Record
88
42
CoreAge RxBrief Score 94 · 58SkinnyRx

Price, coverage & the tracker

CoreAge RxSkinnyRx
Brief Score94/100 (A)58/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$349/mo month-to-month, compounded — the advertised $199 is the 12-month rung, billed as $2,388 in one payment

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$399/mo month-to-month, compounded, injection or tablet at the same price — the advertised $299 is the 12-month rung, billed as $3,588 in one payment

CoverageUS only; restrictions by state, confirmed at intake47 states + Washington DC — not Alabama, Louisiana or Mississippi
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

SkinnyRx: Month-to-month prices are $349 for semaglutide and $399 for tirzepatide; the tirzepatide tablet has the same price as the injection. The $199/$299 monthly equivalents require annual prepayment of $2,388/$3,588 and automatic annual renewal.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.